Sulaf Assi
Dr Sulaf Assi is a senior lecturer in analytical forensic chemistry at the School of Pharmacy and Biomolecular science in Liverpool John Moores University. Her research interests spread across multidisciplinary and interdisciplinary areas related to medication safety; patient safety; counterfeit medicines, drugs and lifestyle products; spectroscopy; mixed-method research and machine learning. She has published 100+ […]
Dr. Archana Bahuguna
Dr. Archana Bahuguna is a Professional with a career spanning over two decades in Pharmaceutical companies – Unichem, Zydus Cadila, Merck KGaA, Pfizer, Accutest, KPMG, Raptakos Brett. She has extensive Global experience in leading Analytical R&D teams supporting development programmes (Phase 1 to Phase 3) for drug substances and drug products for diverse portfolios of […]
Joel Russo
Joel has 30 years of Microbiology experience including nearly 25 years of experience in pharmaceutical and other areas of GMP Manufacturing Quality, Compliance, and GLP Quality Laboratory Processes and Systems, specialised in Microbiological Control, Aseptic Processing, FDA Remediation, Quality Systems remediation in response to regulatory actions, 483’s Warning Letters, Consent Decrees, other regulatory reporting. Leading, […]
Andrew Teasdale
Former Chair of AstraZeneca impurities advisory group. Responsible for the development and oversight of policy relating to all impurity categories, including impurity qualification / genotoxic impurities / metals and extractables & leachables. Expert within the field of Genotoxic Impurities. Editor of the first book specifically focused on the subject matter : Genotoxic Impurities: Strategies for […]
Mark Hallworth
Mark Hallworth is a globally recognized authority in pharmaceutical contamination control, specializing in the design, validation, and implementation of GMP-compliant environmental monitoring systems. With decades of experience, he has led more than 200 projects across cleanroom facilities, focusing on regulatory compliance, data integrity, and system performance. Mark has contributed to the development of particle counters […]
Hayden Skalski
Hayden Skalski serves as the Life Sciences Product Application Specialist for Veolia’s Sievers Analytical Instruments product line, with a specialized focus on bacterial endotoxins testing (BET). With over 12 years of dedicated experience in endotoxin testing and Quality Control Microbiology within the pharmaceutical industry, Hayden has established himself as a recognized expert in the field, regularly presenting on advanced […]
Vanessa Vasadi Figueroa
Vanessa Vasadi Figueroa is a sterility assurance and contamination control leader with more than 20 years of experience supporting pharmaceutical and medical device manufacturers. She advises organizations across the regulatory lifecycle, from process design and microbial risk assessment to inspection readiness and continuous improvement. Her expertise includes aseptic processing, environmental monitoring strategy, and integrated contamination […]
Dr. Raminderpal Singh
Dr Raminderpal Singh is a recognised visionary in the implementation of AI across technology and science-focused industries. He has over 30 years of global experience leading and advising teams, helping early- to mid-stage companies achieve breakthroughs through the effective use of computational modelling. Raminderpal is currently the Global Head of AI and GenAI Practice at […]
Dr. Michael J. Miller
For more than 37 years, he has held numerous R&D, manufacturing, quality, business development and executive leadership roles at Johnson & Johnson, Eli Lilly and Company, Bausch & Lomb, and Microbiology Consultants, LLC. In his current role, Dr. Miller advises multinational companies in the areas of microbiology, quality and regulatory affairs in support of rapid […]
Malcolm Rossi
Dr. Ross has over 35 years experience in the Generics Industry, the last 15 being at corporate level. He has been intimately involved in strategic planning, pipeline management and related activities. His early industrial experience with Teva and Taro were directed primarily to the US markets but later, as President of IPR, a company jointly […]
